EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • June 15th, 2023 • Kiora Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Exclusive License Agreement ("Agreement"), dated June 7, 2023 ("Effective Date"), is by and between Kiora Pharmaceuticals, Inc., a Delaware corporation with offices located at 332 Encinitas Blvd, Suite 102, Encinitas, CA 92024 ("Licensor"), and Sentrx Animal Care, Inc. a Delaware corporation with offices located at 570 West 1700 South, Suite 1400, Salt Lake City, Utah 84115 ("Licensee") (collectively, the "Parties," or each, individually, a "Party").
FIRST AMENDMENTIntellectual Property License Agreement • June 15th, 2023 • Kiora Pharmaceuticals Inc • Pharmaceutical preparations
This First Amendment ("First Amendment") to the Intellectual Property License Agreement dated September 26, 2018 (the "Agreement") is effective as of June 7, 2023 (the "Effective Date"), by and between the Kiora Pharmaceuticals, Inc., a Delaware corporation with an address at 332 Encinitas Blvd, Suite 102, Encinitas, CA 92024 (formerly located at: 271 Waverley Oaks Road, Suite 108, Waltham, MA 02452) ("Kiora"), and Sentrx Animal Care, Inc. a Delaware corporation with an address at 570 West 1700 South, Suite 1400, Salt Lake City, Utah 84115 ("Sentrx"), each a "Party" and collectively, the "Parties").
